This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watanabe, T. Articles by Nagawa, H. Search for Related Content PubMed PubMed Citation Articles by Watanabe, T. Articles by Nagawa, H.

Distal Colorectal Cancers with Microsatellite Instability (MSI) Display Distinct Gene Expression Profiles that Are Different from Proximal MSI Cancers

¹ Department of Surgery, Teikyo University School of Medicine; ² Department of Systematic Clinical Oncology, Graduate School of Medicine and ³ Department of Surgical Oncology, University of Tokyo; ⁴ Postmarketing Research Laboratory, Taiho Pharmaceutical Co., Ltd.; and ⁵ The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Requests for reprints: Toshiaki Watanabe, Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. Phone: 81-3-3964-1231; Fax: 81-3-5375-6097; E-mail: toshwatanabe{at}yahoo.co.jp.

Promoter methylation of the mismatch repair gene plays a key role in sporadic microsatellite instability (MSI) colorectal cancers. However, promoter methylation often occurs in proximal colon cancers, and molecular phenotypes underlying MSI cancers in distal colon have not been fully clarified. Our goal was to clarify the difference between MSI and microsatellite stability (MSS) cancers and, furthermore, to determine distinct characteristics of proximal and distal MSI cancers. By DNA microarray analysis of 84 cancers (33 MSI and 51 MSS), we identified discriminating genes (177 probe sets), which predicted MSI status with a high accuracy rate (97.6%). These genes were related to phenotypic characteristics of MSI cancers. Next, we identified 24 probe sets that were differentially expressed in proximal and distal MSI cancers. These genes included promoter methylation-mediated genes, whose expression was significantly down-regulated in proximal MSI cancers. Among discriminating genes between MSI and MSS, nine methylation-mediated genes showed down-regulation in MSI cancers. Of these, 7 (77.8%) showed down-regulation in proximal MSI cancers. Furthermore, methylation-specific PCR confirmed that frequency of hMLH1 promoter methylation was significantly higher in proximal MSI cancers (P = 0.0317). These results suggested that there is a difference between proximal and distal MSI cancers in methylation-mediated influence on gene silencing. In conclusion, using DNA microarray, we could distinguish MSI and MSS cancers. We also showed distinct characteristics of proximal and distal MSI cancers. The inactivation form of hMLH, per se, differed between proximal and distal MSI cancers. These results suggested that distal MSI cancers constitute a distinct subgroup of sporadic MSI cancers. (Cancer Res 2006; 66(20): 9804-8)

This article has been cited by other articles:

				S. de Vogel, B. W.C. Bongaerts, K. A.D. Wouters, A. D.M. Kester, L. J. Schouten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. van Engeland, et al. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer Carcinogenesis, September 1, 2008; 29(9): 1765 - 1773. [Abstract] [Full Text] [PDF]

				T. Watanabe, Y. Yamamoto, H. Yamada, T. Hayama, Y. Aoyagi, K. Nakamura, H. Shibuya, and T. Kobunai Survival in Microsatellite-Unstable Colorectal Cancer Clin. Cancer Res., April 15, 2008; 14(8): 2516 - 2516. [Full Text] [PDF]

				D. Cervi, T.-T. Yip, N. Bhattacharya, V. N. Podust, J. Peterson, A. Abou-Slaybi, G. N. Naumov, E. Bender, N. Almog, J. E. Italiano Jr, et al. Platelet-associated PF-4 as a biomarker of early tumor growth Blood, February 1, 2008; 111(3): 1201 - 1207. [Abstract] [Full Text] [PDF]